Clinical Trials Browser

Phase 2 × Neuroectodermal Tumors, Primitive, Peripheral × cixutumumab × Clear all

Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00668148 2018-07-17

A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma

Phase 2 Completed

113 enrolled 13 charts

Sarcoma

Leiomyosarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Sarcoma, Synovial, Neuroectodermal Tumors, Primitive, Peripheral, Neuroectodermal Tumors, Primitive

Clinical Trials

Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma

A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma